Systemic identification of estrogen-regulated genes in breast cancer cells through cap analysis of gene expression mapping.

[1]  K. Horie-Inoue,et al.  RNA Sequencing of MCF-7 Breast Cancer Cells Identifies Novel Estrogen-Responsive Genes with Functional Estrogen Receptor-Binding Sites in the Vicinity of Their Transcription Start Sites , 2013, Hormones and Cancer.

[2]  G. M. Di Guglielmo,et al.  GPR54 (KISS1R) Transactivates EGFR to Promote Breast Cancer Cell Invasiveness , 2011, PloS one.

[3]  G. Neufeld,et al.  Receptor activity modifying protein‐3 mediates the protumorigenic activity of lysyl oxidase‐like protein‐2 , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[5]  D. Vaux,et al.  Inhibition of Bak Activation by VDAC2 Is Dependent on the Bak Transmembrane Anchor* , 2010, The Journal of Biological Chemistry.

[6]  O. De Wever,et al.  Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis. , 2010, Journal of the National Cancer Institute.

[7]  Krishna Rao,et al.  Tumor suppressor function of Rab25 in triple‐negative breast cancer , 2010, International journal of cancer.

[8]  K. Horie-Inoue,et al.  Knockdown of Efp by DNA-modified small interfering RNA inhibits breast cancer cell proliferation and in vivo tumor growth , 2010, Cancer Gene Therapy.

[9]  Kevin P. Claffey,et al.  Differential protein expression profiles in estrogen receptor-positive and -negative breast cancer tissues using label-free quantitative proteomics. , 2010, Genes & cancer.

[10]  Pin-i Chen,et al.  Rab5 Isoforms Differentially Regulate the Trafficking and Degradation of Epidermal Growth Factor Receptors* , 2009, The Journal of Biological Chemistry.

[11]  B. Kreike,et al.  The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation. , 2008, Cancer research.

[12]  B. Katzenellenbogen,et al.  Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer. , 2008, Cancer research.

[13]  H. Aburatani,et al.  Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis , 2007, Oncogene.

[14]  Zhongyi Zhang,et al.  GAS6 is an estrogen-inducible gene in mammary epithelial cells. , 2007, Biochemical and biophysical research communications.

[15]  S. Vacher,et al.  Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. , 2006, Endocrine-related cancer.

[16]  Clifford A. Meyer,et al.  Genome-wide analysis of estrogen receptor binding sites , 2006, Nature Genetics.

[17]  M. Merino,et al.  Rab11a Differentially Modulates Epidermal Growth Factor-induced Proliferation and Motility in Immortal Breast Cells , 2006, Breast Cancer Research and Treatment.

[18]  Martin S. Taylor,et al.  Genome-wide analysis of mammalian promoter architecture and evolution , 2006, Nature Genetics.

[19]  C. Kai,et al.  CAGE: cap analysis of gene expression , 2006, Nature Methods.

[20]  P. Chambon,et al.  The estrogen-responsive adrenomedullin and receptor-modifying protein 3 gene identified by DNA microarray analysis are directly regulated by estrogen receptor. , 2006, Journal of molecular endocrinology.

[21]  J. Robertson,et al.  Overview of tyrosine kinase inhibitors in clinical breast cancer. , 2005, Endocrine-related cancer.

[22]  E. Rosen,et al.  BRCA1 Inhibits Membrane Estrogen and Growth Factor Receptor Signaling to Cell Proliferation in Breast Cancer , 2004, Molecular and Cellular Biology.

[23]  R. Kiyama,et al.  Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells. , 2004, Journal of molecular endocrinology.

[24]  J. Kawai,et al.  Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Korsmeyer,et al.  VDAC2 Inhibits BAK Activation and Mitochondrial Apoptosis , 2003, Science.

[26]  P H Watson,et al.  Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma , 2003, British Journal of Cancer.

[27]  C. Klinge.  Estrogen receptor interaction with estrogen response elements. , 2001, Nucleic acids research.

[28]  S. Inoue,et al.  Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors alpha and beta. , 1997, Biochemical and biophysical research communications.

[29]  B. Henderson,et al.  Estrogens and breast cancer. , 1996, Carcinogenesis.

[30]  M. Johnson,et al.  Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. , 1990, The Journal of biological chemistry.

[31]  J. Farndon,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER , 1987, The Lancet.

[32]  O. Hf.  THE FAYUM EXPEDITION OF THE AMERICAN MUSEUM. , 1907 .

[33]  J. Pouysségur,et al.  Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. , 2009, Cancer research.

[34]  大石 陽子.  Functional pathway characterized by gene expression analysis of supraclavicular lymph node metastasis-positive breast cancer , 2006 .

[35]  R. Kiyama,et al.  Transcription factor EGR 3 is involved in the estrogen-signaling pathway in breast cancer cells , 2004 .

[36]  R. Weigel,et al.  PDZK 1 and GREB 1 Are Estrogen-regulated Genes Expressed in Hormone-responsive Breast Cancer 1 , 2 , 2000 .